SCHEMBL1614903

SCHEMBL1614903

CCCC(CC)CN1C(=O)S/C(=C\c2cc(Br)cc(Br)c2)C1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.51
▸ KMT2A Q03164 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CISD1 Q9NZ45 2/20 0.43
▸ MYC P01106 1/20 0.40
▸ MAX P61244 1/20 0.40
▸ COMT P21964 1/20 0.39
▸ MCL1 Q07820 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ PPARG P37231 1/20 0.37
▸ BAG3 O95817 1/20 0.37
▸ CGAS Q8N884 1/20 0.37
▸ MAOA P21397 1/20 0.37
▸ MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1613879 0.93 SLC2A1 (0.57) SLC2A1KMT2AALDH1A1KDM4ETHRB
SCHEMBL12712459 0.83 CISD1 (0.46) SLC2A1KMT2AALDH1A1KDM4ETHRB
SCHEMBL1614287 0.82 MCL1 (0.47) SLC2A1KMT2AALDH1A1KDM4ECISD1
SCHEMBL1614901 0.78 SLC2A1 (0.69) SLC2A1KMT2AALDH1A1KDM4ETHRB
SCHEMBL16492058 0.74 SLC2A1 (0.54) SLC2A1KMT2AALDH1A1KDM4ECOMT
SCHEMBL12712445 0.73 SLC2A1 (0.61) SLC2A1KMT2AALDH1A1KDM4ETHRB
SCHEMBL16492057 0.71 SLC2A1 (0.55) SLC2A1KMT2AALDH1A1CISD1COMT
SCHEMBL12712427 0.71 SLC2A1 (0.73) SLC2A1KMT2AALDH1A1KDM4ETHRB
SCHEMBL1612918 0.71 PPARG (0.50) KMT2AALDH1A1KDM4EMCL1MEN1
SCHEMBL1614757 0.70 ENPP2 (0.61) KMT2AALDH1A1MEN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 — — EP claimed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO claimed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US claimed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 — — EP disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS PCK2, AK2, SIRT6 SLC2A1 76/4885KMT2A 1663/4885ALDH1A1 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback